Operating Lease, Right-of-Use Asset of Climb Bio, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Climb Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Climb Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $562,000, a 4583% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Climb Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$562,000	+$550,000	+4583%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$618,000	+$597,000	+2843%	30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	$451,000	+$340,000	+306%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$490,000	+$291,000	+146%	31 Dec 2024	10-Q	06 Nov 2025	2025	Q3
Q3 2024	$12,000	-$274,000	-96%	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$21,000	-$351,000	-94%	30 Jun 2024	10-Q	14 Aug 2024	2024	Q2
Q1 2024	$111,000	-$551,000	-83%	31 Mar 2024	10-Q	15 May 2024	2024	Q1
Q4 2023	$199,000	-$272,000	-58%	31 Dec 2023	10-K	25 Mar 2025	2024	FY
Q3 2023	$286,000	-$299,000	-51%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$372,000	-$325,000	-47%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$662,000	-$145,000	-18%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$471,000	+$471,000		31 Dec 2022	10-K	28 Mar 2024	2023	FY
Q3 2022	$585,000			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$697,000			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$807,000			31 Mar 2022	10-Q	16 May 2022	2022	Q1
Q4 2021	$0			31 Dec 2021	10-K	06 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.